|
第六章 參考文獻
1.Rook GA, and Stanford JL, Give us this day our daily germs. Immunol Today 1998, 19: 113—6
2.Horwood IL, Fergusson DM, and Shannon FT, Social and familial factors in the development of early childhood asthma. Pediatrics 1985, 75: 859—868
3.Sporik R, Holgate ST, and Cogswell JJ, Natural history of asthma in childhood─a birth cohort study. Arch Dis Child 1991, 66: 1050—1053
4.Clifford RD, Howell JB, Radford M, and Holgate ST, Associations between respiratory symptoms, bronchial response to methacholine and atopy in two age groups of school children. Arch Dis Child 1989, 64: 1133—1139
5.Peat JK, Salome CM, and Woolcock AJ, Longitudinal changes in atopy during a 4-year period: relation to bronchial hyperresponsiveness and respiratory symptoms in a population sample of Australian schoolchildren. J Allergy Clin Immunol 1990, 85: 65—74
6.Martin AJ, Landau LI, and Phelan PD, Natural history of allergy in asthmatic children followed to adult life. Med J 1981, 2: 470—474
7.Marsh DG, Hsu SH, and Roebber M et al., HLA-Dw2: a genetic marker for human immune response to short ragweed pollen allergen Ra 5 I Response resulting primarily from natural antigenic exposure. J Exp Med 1982, 155: 1439—51
8.Marsh DG, Neely JD, and Breazeale DR et al., Linkage analysis of IL-4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science 1994, 264: 1152—5
9.Baldini M, Lohman IC, Halonen M, Erickson RP, Holt PG, and Martinez FD, A polymorphism in the 5’-flanking region of the CD14 gene is associated with circulating soluble CD14 levels with total serum IgE. Am J Respir Cell Mol Biol 1999, 20: 976—83
10.Peat JK, The epidemiology of asthma. Curr Opin PulmonŽ Med 1996, 21: 7-15
11.Kurup VP, and Kumar A, Immunodiagnosis of aspergillosis. Clin Microbiol Rev 1991, 4: 439 —59
12.Stewart GA, and Thompson PJ, The biochemistry of common aeroallergens. Clin Exp Allergy 1996, 26: 1020—44
13.Valenta R, and Kraft D, Recombinant allergens for diagnosis and therapy of allergic diseases. Curr Opin Immunol 1995, 7: 751— 6
14.Valenta R, Steinberger P, Duchene M, and Kraft D, Immunological and structural similarities among allergens: prerequisite for a specific and component-based therapy of allergy. Immunol Cell Biol 1996, 74: 187—94
15.Kauffman HF, Tomee JFC, van der Werf TS, de Monchy JG, and Koeter GK, Review of fungus-induced asthmatic reactions. Am J Respir Crit Care Med 1995, 151: 2109—16
16.Valenta R, Vrtala S, Spitzauer S, and Kraft D, Recombinant allergens. Allergy 1998, 53: 552-561
17.Janeway CA, Travers P, Walport M, and Capra JD, Immunobiology: The immune system in health and disease. 1999, 4th ed., p462-488
18.Barnes PJ, Pathophysiology of asthma. Br J Clin Pharmacol 1996, 42: 3-10
19.Anderson GP, and Coyle AJ, Th2 and ‘Th2-like’ cells in allergy and asthma: Pharmacological perspectives. Trends Pharmacol Sci 1994, 15: 324-332
20.Shi H, Qin S, Huang G, Chen Y, Xiao C, Xu H, Liang G, Xie Z, Qin X, Wu J, Li G and Zhang C, Infiltration of eosinophils into the asthmatic airways caused by interleukin 5. Am J Respir Cell Mol Biol 1997, 16: 220-224
21.Scharenberg AM, and Kinet JP, Initial events in FcεRI signal transduction. J Allergy Clin Immunol 1994, 94: 1142-1146
22.Wuethrich B, Epidemiology of allergic diseases: Are they really on the increase. Int Arch Allergy Appl Immunol 1989, 90: 3—10
23.Latge JP, Paris S, The fungal spore and disease initiaton in plants and animals, in: Cole G.T., Moch H.C. (Eds.), Plenum Press, New York, 1991, pp. 379—401
24.Portnoy J, Chapman J, Burge H, Muieleberg M, SolomonW, Epicoccum allergy. Skin reaction patterns and spore/mycelium disparities recognized by IgG and IgE ELISA inhibition. Ann Allergy 1987, 59: 39—43
25.Burge HA, Airborne-allergenic fungi. Immunol Allergy Clin North Am 1989, 9: 307—319
26.Kurup VP, Fink JN, in: Murphy JW, Friedman H, Bendinelli M (Eds.), Fungal Infection and Immunity Responses, Plenum Press, New York, 1993, pp. 393—404
27.Kurup VP, Hypersensitivity pneumonitis due to sensitization with thermophilic actinomycetes. Immunol. Allergy Clin North Am 1989, 9: 285—306
28.Achatz G, Oberkofler H, Lechenauer E, Simon B, Unger A, Kandler D, Ebner C, Prillinger H, Kraft D, and Breitenbach M, Molecular cloning of major and minor allergens of Alternaria alternata and Cladosporium herbarum. Mol Immunol 1995, 32: 213—227
29.Vijay HM, Thaker AJ, Banerjee B, and Kurup VP, Allergens and Allergen Immunotherapy, in: Lockey R.F., Bukantz S.C. (Eds.), Marcel Dekker, Inc., New York, 1999, pp. 133—154
30.Beaumont F, Kauffman HF, Sluiter HJ, and De Vries K, Sequential sampling of fungal air spores inside and outside the homes of mold sensitive, asthmatic patients: a search for a relationship to obstructive reactions. Ann Allergy 1985, 55: 740—746
31.Miller JD, Fungi as contaminants in indoor air. Atmospheric Environment 1992, 26 A: 2163-2172
32.Horner WE, Helbling A, and Lehrer SB, Basidiomycete allergens. Allergy 1998, 53: 1114-21
33.Horner WE, Reese G, and Lehrer SB, Identification of the allergen Psi c 2 from the Basidiomycete Psilocybe cubensis as a fungal cyclophilin. Int Arch Allergy Immunol 1995, 107: 298-300
34.Licorish K, Novey HS, Kozak P, Fairshter RD, and Wilson AF, Role of Alternaria and Penicillium spores in the pathogenesis of asthma. J Allergy Clin Immunol 1985, 76: 819-825
35.Malling HJ, Diagnosis and immunotherapy of mould allergy. IV. Relation between asthma symptoms, spore counts and diagnostic tests. Allergy 1986, 41: 342-350
36.Helbling A, Horner WE, and Lehrer SB, Comparison of Psilocybe cubensis spore and mycelium allergens. J Allergy Clin Immunol 1993, 91: 1059-1066
37.Hoffman DR, and Kozak PP, Shared and specific allergens in mold extracts. J Allergy Clin Immunol 1979, 63: 267-272
38.Lopez M, Butcher BT, Salvaggio JE, Olson JA, Reed MA, McCants ML, and Lehrer SB, Basidiomycete allergy: what is the best source of antigen? Int Arch Allergy Appl Immunol 1985, 77: 169-170
39.Paris S, Fitting C, Latge JP, Hermann D, Guinnepain MT, and David B, Comparison of conidial and mycelial allergens of Alternaria alternata. Int Arch Appl Immunol 1990, 92: 1-8
40.Wahl R, Oliver JD, Hauck PR, Winter HG, and Maasch HJ, Comparison of Alternaria tenuis extracts prepared from different raw ma-terials. Ann Allergy 1989, 63: 527-531
41.Weissman DN, Halmepuro L, Salvaggio JE, and Lehrer SB, Antigenic/allergenic analysis of basidiomycete cap, mycelia, and spore ex-tracts. Int Arch Allergy Appl Immunol 1987, 84: 56-61
42.Burge HA, Fungus allergens. Clin Rev Allergy 1985, 3: 319-329
43.Savolainen JM, Viander R, Einarsson, and Koivikko A, Allergenic variability of different strains of Candida albicans. Int Arch Allergy Appl Immunol 1989, 90: 61-66
44.Orme, IM, Andersen P, and Boom WH, T cell response to Mycobacterium tuberculosis. J Infect Dis 1993, 167: 1481-1497
45.Van Ganse E, Kaufman L, Derde MP, Yernault JC, Delaunois L, and Vincken W, Effects of antihistamines in adult asthma: a meta-analysis of clinical trials. Eur Respir J 1997, 10: 2216-24
46.Drazen JM, Israel E, and O'Byrne PM, Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med 1999, 340: 197-206
47.In KH, Asano K, Beier D, Grobholz J, Finn PW, Silverman EK, Silverman ES, Collins T, Fischer AR, Keith TP, Serino K, Kim SW, De Sanctis GT, Yandava C, Pillari A, Rubin P, Kemp J, Israel E, Busse W, Ledford D, Murray JJ, Segal A, Tinkleman D, and Drazen JM, Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription. J Clin Invest 1997, 99(5): 1130-7
48.Borish LC, Nelson HS, Lanz MJ, Claussen L, Whitmore JB, Agosti JM, and Garrison L, Interleukin-4 receptor in moderate atopic asthma. A phase I/II randomized, placebo-controlled trial. Am J Respir Crit Care Med 1999, 160: 1816- 1823
49.Luster AD, Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 1998, 338(7): 436-45
50.Heath H, Qin S, Rao P, Wu L, LaRosa G, Kassam N, Ponath PD, and Mackay CR, Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody. J Clin Invest 1997: 99(2): 178-84
51.Creticos PS, Immunotherapy with allergens. J Am Med Assoc 1992, 268: 2834-2839
52.Bousquet J, Lockey R, Malling HJ, Alvarez-Cuesta E, Canonica GW, Chapman MD, Creticos PJ, Dayer JM, Durham SR, Demoly P, Goldstein RJ, Ishikawa T, Ito K, Kraft D, Lambert PH, Lowenstein H, Muller U, Norman PS, Reisman RE, Valenta R, Valovirta E, and Yssel H, Allergen immunotherapy: therapeutic vaccines for allergic diseases. Ann Allergy Asthma Immunol 1998, 81: 401-405
53.Durham SR, Walker SM, Varga EM, Jacobson MR, O’Brien F, Noble W, Till SJ, Hamid QA, and Nouri-Aria KT, Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 1999, 341: 468-475
54.Secrist H, DeKruyff RH, and Umetsu DT, Interleukin 4 production by CD4+ cells from allergic individuals is modulated by allergen concentration and antigen-presenting cell type. J Exp Med 1995, 181: 1081-1090
55.HayGlass KT, and Stefura BP, Anti-interferonγtreatment blocks the ability of glutaraldehyde-polymerized allergens to inhibit specific IgE responses. J Exp Med 1991, 173: 279-285
56.Smith AM, and Chapman MD, Reduction in IgE binding to allergen variants generated by site-directed mutagenesis: contribution of disulfide bonds to the antigenic structure of the major house dust mite allergen Der p 2. Mol Immunol 1996, 33: 399-405
57.Norman PS, Ohman JLJr, Long AA, Creticos PS, Gefter MA, Shaked Z, Wood RA, Eggleston PA, Hafner KB, and Rao P, Treatment of cat allergy with T-cell reactive peptides. Am J Respir Crit Care Med 1996, 154: 1623-1628
58.Pene J, Desroches A, Paradis L, Lebel B, Farce M, Nicodemus CF, Yssel H, and Bousquet J, Immunotherapy with Feld 1 peptides decreases IL-4 release by peripheral blood T cells of patients allergic to cats. J Allergy Clin Immunol 1998, 101: 571-578
59.Maguire P, Nicodemus C, Aaronson D, Robinson D, and Umetsu DT, The safety and efficacy of ALLERVAX CAT in cat allergic patients. Clin Immunol 1999, 93: 222-231
60.Haselden BM, Kay BA, and Larche M, Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide-induced late asthmatic reactions. J Exp Med 1999, 189: 1885-1894
61.La Rosa M, Ranno C, Andre C, Carat F, Tosca MA, Canonica GW, Double-blind placebo-controlled evalution of sublingual-swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 1999, 104: 425-432
62.Passalacqua G, Albano M, Riccio A, Fregonese L, Puccinelli P, Parmiani S, and Canonica GgW, Clinical and immunologic effects of a rush sublingual immunotherapy to Parietaria species: A double-blind, placebo-controlled trial. J Allergy ClinImmunol 1999, 104: 964-968
63.Faria AM, and Weiner H L, Oral tolerance: Mechanisms and therapeutic applications. Adv Immunol 1999, 73: 153-264
64.Ulmer JB, Donnelly JJ, Parker SE, Rhodes GH, Felgner PL, Dwarki, VJ, Gromkowski SH, Deck RR, DeWitt CM, and Friedman A, et al., Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993, 259: 1745-1749
65.Condon C, Watkins SC, Celluzzi CM, Thompson K, and Falo LD, Jr, DNA-based immunization by in vivo transfection of dendritic cells. Nature Med 1996, 2: 1122-1128
66.Tascon RE, Colston MJ, Ragno S, Stavropoulos E, Greg-ory D, and Lowrie DB, Vaccination against tuberculosis by DNA injection. Nature Med 1996, 2: 888-892
67.Waisman A, Ruiz PJ, Hirschberg DL, Gelman A, Oksen-berg JR, Brocke S, Mor F, Cohen IR, and Steinman L, Suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity. Nature Med 1996, 2: 899-905
68.Seder RA, and Gurunathan S, DNA vaccines─Designer vaccines for the 21st century. N Engl J Med 1999, 341: 277—278
69.Raz E, Tighe H, Sato Y, Corr M, Dudler JA, Roman R, Swain SL, Spiegelberg HL, and Carson DA, Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc Natl Acad Sci USA 1996, 93: 5141-5145
70.Hsu CH, Chua KY, Tao MH, Lai YL, Wu HD, Huang SK, and Hsieh KH, Immunoprophylaxis of allergen-induced immunoglobulin E synthesis and airway hyperresponsiveness in vivo by genetic immunization. Nature Med 1996, 2: 540-544
71.Roy K, Mao HQ, Huang SK, and Leong KW, Oral gene delivery with chitosan─DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nature Med 1999, 5: 387-391
72.Dianne C, Rosemarie HD, and Dale TU, Allergen immunotherapy: noval approaches in the management of allergic diseases and asthma. Clin Immunol 2000, 97: 193-202
73.Kim TS, DeKruyff RH, Rupper R, Maecker HT, Levy S, and Umetsu DT, An OVA-IL-12 fusion protein is more effective than OVA plus rIL-12 in inducing a Th1-dominated immune response and inhibiting antigen-specific IgE production. J Immunol 1997, 158: 4137-4144
74.Sato Y, Roman M, Tighe H, Lee D, Corr M, Nguyen MD, Silverman GJ, Lotz M, Carson DA, and Raz E, Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 1996, 273: 352-354
75.Bohle B, Jahn-Schmid B, Maurer D, Kraft D, and Ebner C, Oligodeoxynucleotides containing CpG motifs induce IL-12, IL-18 and IFN-gamma production in cells from allergic individuals and inhibit IgE synthesis in vitro. Eur J Immunol 1999, 29: 2344-2353
76.Shirota H, Sano K, Kikuchi T, Tamura G, and Shirato K, Regulation of murine airway eosinophilia and Th2 cells by antigen-conjugated CpG oligodeoxynucleotides as a novel antigen-specific immunomodulator. J Immunol 2000, 164: 5575-5582
77.Erb KJ, Holloway JW, Sobeck A, Moll H, and Le Gros G, Infection of mice with Mycobacterium bovis-bacillus Calmette-Gue´rin (BCG) suppresses allergen-induced airway eosinophilia. J Exp Med 1998, 187: 561-569
78.Gravesen S, Indoor air bone mold spores. Allergy 1985, 40: 21-23
79.Nissen D, Petersen LJ, Esch R, Svejgaard E, Skov PS, Poulsen LK, and Nolte H, IgE-sensitization to cellular and culture filtrates of fungal extracts in patients with atopic dermatitis. Ann Allergy Asthma Immunol 1998, 81: 247-255
80.Wijnands LM, Deisz WD, and van Leusden FM, Marker antigens to assess exposure to molds and their allergens. Allergy 2000, 55: 850-855
81.Banerjee B, Greenberger PA, Fink JN, and Kurup VP, Immunological characterization of Asp f 2, a major allergen from Aspergillus fumigatus associated with allergic bronchopulmonary aspergillosis. Infect Immun 1998, 66: 5175-5182
82.Peterbauer CK, Lorito M, Hayes CK, Harman GE, and Kubicek CP, Molecular cloning and expression of the nag1 gene (N-acetyl-beta-D—glucosaminidase- encoding gene) from Trichoderma harzianum P1. Curr Genet 1996, 30(4): 325-31
83.Su NY, Yu CJ, Shen HD, Pan FM, and Chow LP, Pen c 1, a novel enzymic allergen protein from Penicillium citrinum. Purification, characterization, cloning and expression. European J Biol Chem 1999, 261(1): 115-23
84.Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, and Klenk DC, Measurement of protein using bicinchoninic acid. Anal Biochem 1985, 150(1): 76-85
85.Gorg A, Postel W, and Gunther S, The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 1988, 9(9): 531-46
86.Moritz RL, Eddes JS, Reid GE, and Simpson RJ, S-pyridylethylation of intact polyacrylamide gels and in situ digestion of electrophoretically separated proteins: a rapid mass spectrometric method for identifying cysteine-containing peptides. Electrophoresis 1996, 17: 907-917
87.Zacharius RM, Zell TE, Morrison JH, and Woodlock JJ, Glycoprotein staining following electrophoresis on acrylamide gels. Anal Biochem 1969, 30: 148-152
88.Diez B, and Barredo JL, The beta-N-acetylhexosaminidase encoding gene from Penicillium chrysogenum. NCBI-Accession number: AF056977
89.King TP, Hoffman D, Lowenstein H, Marsh DG, Platts-Mills TAE, and Thomas W, Allergen nomenclature. WHO/IUIS Allergen Nomenclature Subcommittee. Int Arch Allergy Immunol 1994, 105: 224-233
90.Lortio M, Hayes CK, Pietro ADi, Woo SL, and Harman GE, Purification, characterization, and synergistic activity of a glucan 1,3-β-glucosidase and an N-acetyl-β-glucosaminidase from Tricoderma harzianum. Phytopathology 1994, 84: 398-405.
91.Cannon RD, Niimi K, Jenkinson HF, Shepherd MG, Molecular cloning and expression of the Candida albicans beta-N-acetylglucosaminidase (HEX1) gene. J Bacteriol 1994, 176(9): 2640-7
92.Kurup VP, Fink JN, Scribner GH, and Falk J, Antigenic variability of Aspergillus fumigatus strains, Microbios 1977, 19: 191—204
93.Herz U, Gerhold K, Gruber C, Braun A, Wahn U, Renz H, and Paul K, BCG infection suppresses allergic sensitization and development of increased airway reactivity in an animal model. J Allergy Clin Immunol 1998, 102(5): 867-74
94.Chow LP, Liu SL, Yu CJ, Liao HK, Tsai JJ, Tang TK, Identification and expression of an allergen Asp f 13 from Aspergillus fumigatus and epitope mapping using human IgE antibodies and rabbit polyclonal antibodies. Biochem J 2000, 346: 423-31
95.Tomee JF, Wierenga AT, Hiemstra PS, and Kauffman HK, Proteases from Aspergillus fumigatus induce release of proinflammatory cytokines and cell detachment in airway epithelial cell lines. J Infect Dis 1997, 176(1): 300-3
96.Kurup VP, and Banerjee B, Fungal allergens and peptide epitopes. Peptides 2000, 21: 589-599
97.Hounsell EF, Methods in molecular biology: Glycoprotein analysis in biomedicine. 1993, p25-26
98.Sanon A, Lawrence F, Bories C, and Loiseau PM., Purification of N-acetyl-beta-D-hexosaminidase from Trichomonas vaginalis. Exp Parasitol 2001, 97: 169-172
99.Huby RD, Dearman RJ, and Kimber I, Why are some proteins allergens? Toxicol Sci 2000, 55: 235-246
100.Aalberse RC, Koshte V, and Clemens JGJ, Immunoglobulin E antibodies that crossreact with vegetable foods, pollen, and Hymenoptera venom. J Allergy Clin Immunol 1981, 68, 356—364
101.Aalberse RC, and van ReeR, Crossreactive carbohydrate determinants. Clin Rev Allergy Immunol 1997, 15: 375-387
102.van Ree R, Cabanes-Macheteau M, Akkerdaas J, Milazzo JP, Loutelier-Bourhis C, Rayon C, Villalba M, Koppelman S, Aalberse R, Rodriguez R, Faye L, Lerouge P, Beta(1,2)-xylose and alpha(1,3)-fucose residues have a strong contribution in IgE binding to plant glycoallergens. J Biol Chem 2000, 275: 11451-11458
103.Petersen A, Schramm G, Schlaak M, and Becker WM, Post-translational modifications influence IgE reactivity to the major allergen Phl p 1 of timothy grass pollen. Clin Exp Allergy 1998, 28: 315-321
104.Weber A, Schroder H, Thalberg K, and Marz L, Specific interaction of IgE antibodies with a carbohydrate epitope of honey bee venom phospholipase A2. Allergy 1987, 42: 464-470
105.Batanero E, Villalba M, and Rodriguez R, Glycosylation site of the major allergen from olive tree pollen. Allergenic implications of the carbohydrate moiety. Mol Immunol 1994, 31: 31-37
106.Tretter V, Altmann F, Kubelka V, März L, and Becker WM, Fucose alpha 1,3-linked to the core region of glycoprotein N-glycans creates an important epitope for IgE from honeybee venom allergic individuals, Int Arch Allergy Immunol 1993, 102: 259-266
107.Mouritsen S, Meldal M, Christiansen-Brams I, Elsner H., and Werdelin O, Attachment of oligosaccharides to peptide antigen profoundly affects binding to major histocompatibility complex class II molecules and peptide immunogenicity. Eur J Immunol 1994, 24: 1066-1072
108.Corthay A, Bäcklund J, Broddefalk J, Michaëlsson E, Goldschmidt TJ, Kihlberg J, and Holmdahl R, Epitope glycosylation plays a critical role for T cell recognition of type II collagen in collagen-induced arthritis. Eur J Immunol 1998, 28: 2580-2590
109.Manoury B, Hewitt EW, Morrice N, Dando PM, Barrett AJ, and Watts C, An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation. Nature 1998, 396: 695-699
110.Agnes MC, Tan A, Jordens R, Geluk A, Roep BO, Ottenhoff T, Drijfhout JW, and Koning F, Strongly increased efficiency of altered peptide ligands by mannosylation. Int Immunol 1998, 10: 1299-1304
111.Jansen RW, Molema G, Ching TL, Oosting R, Harms G, Moolenaar F, Hardonk MJ, and Meijer DK, Hepatic endocytosis of various types of mannose-terminated albumins. What is important, sugar recognition, net charge, or the combination of these features. J Biol Chem 1991, 266: 3343-3348
112.Kindberg GM, Magnusson S, Berg T, and Smedsrød B, Receptor-mediated endocytosis of ovalbumin by two carbohydrate-specific receptors in rat liver cells. The intracellular transport of ovalbumin to lysosomes is faster in liver endothelial cells than in parenchymal cells. Biochem J 1990, 270: 197—203
113.Condaminet B, Péguet-Navarro J, Stahl PD, Dalbiez-Gauthier C, Schmitt D, and Berthier-Vergnes O, Human epidermal Langerhans cells express the mannose-fucose binding receptor. Eur J Immunol 1998, 28: 3541-3551
114.Engering AJ, Cella M, Fluitsma D, Brockhaus M, Hoefsmit EC, Lanzavecchia A, and Pieters J, The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cells. Eur J Immunol 1997, 27: 2417-2425
115.Jiang W, Swiggard WJ, Heufler C, Peng M, Mirza A, Steinman RM., and Nussenzweig MC, The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature 1995, 375: 151-155
116.Hewlett LJ, Prescott AR, and Watts C, The coated pit and macropinocytic pathways serve distinct endosome populations. J Cell Biol 1994, 124: 689-703
117.Lutz MB, Rovere P, Kleijmeer MJ, Rescigno M, Assmann CU, Oorschot VM, Geuze H J, Trucy J, Demandolx D, Davoust J, and Ricciardi-Castagnoli P, Intracellular routes and selective retention of antigens in mildly acidic cathepsin D/lysosome-associated membrane protein-1/MHC class II-positive vesicles in immature dendritic cells. J Immunol 1997, 159: 3707-3716
118.Flindt ML, Pulmonary disease due to inhalation of derivatives of Bacillus subtilis containing proteolytic enzyme. Lancet 1969, 1: 1177-1181
119.Pham QT, and Mire B, Respiratory manifestations and skin reactivity in the detergent industry. J Occup Med 1978, 20: 33-38
120.Baur X, König G, Bencze K, and Fruhmann G, Clinical symptoms and results of skin test, RAST and bronchial provocation test in thirty-three papain workers: evidence for strong immunogenic potency and clinically relevant proteolytic effects of airborne papain. Clin Allergy 1982, 12: 9-17
121.Quirce S, Cuevas M., Díez-Gómez M., Fernández-Rivas M, Hinojosa M, González, R, and Losada E, Respiratory allergy to Aspergillus-derived enzymes in bakers' asthma. J Allergy Clin Immunol 1992, 90: 970-978
122.Herbert CA, King CM, Ring PC, Holgate ST, Stewart GA, Thompson PJ, and Robinson C, Augmentation of permeability in the bronchial epithelium by the house dust mite allergen Der p1. Am J Respir Cell Mol Biol 1995, 12: 369-378
123.Hewitt CR, Brown AP, Hart BJ, and Pritchard DI, A major house dust mite allergen disrupts the immunoglobulin E network by selectively cleaving CD23: innate protection by antiproteases. J Exp Med 1995, 182: 1537-1544
124.Schulz O, Laing P, Sewell H F, and Shakib F, Der p I, a major allergen of the house dust mite, proteolytically cleaves the low-affinity receptor for human IgE (CD23). Eur J Immunol 1995, 25: 3191-3194
125.Shakib F, Schulz O, and Sewell H, A mite subversive: cleavage of CD23 and CD25 by Der p 1 enhances allergenicity. Immunol Today 1998, 19: 313-316
126.Chapman MD, Smith AM, Vailes LD, Arruda LK, Dhanaraj V, Pomes A, Recombinant allergens for diagnosis and therapy of allergic disease. J Allergy Clin Immunol 2000, 106: 409-418
127.Pomés A, Chapman MD, Blundell TL, Dhanaraj V, Comparative modeling of Bla g 2, a cockroach allergen and inactive aspartic proteinase. J Allergy Clin Immunol 2000, 105: S168-172
128.Arruda LK, Vailes LD, Benjamin DC, Chapman MD, Molecular cloning of a major cockroach allergen, Bla g 2. J Biol Chem 1995, 270: 19563-8
129.Cooper JB, Khan G, Taylor G, Tickle IJ, and Blundell TL, X-ray analyses of aspartic proteinases, II: three-dimensional structure of the hexagonal crystal form of porcine pepsin at 2.3 Å ± resolution. J Mol Biol 1990, 214: 199-222
130.Van der Veen MJ, Mulder M, Witteman AM, van Ree R, Aalberse RC, Jansen HM., False-positive skin prick test responses to commercially available dog dander extracts caused by contamination with house dust mite (Dermatophagoides pteronyssinus) allergens. J Allergy Clin Immunol 1996, 98: 1028-34
131.Esch RE, Role of proteases on the stability of allergenic extracts. Arb Paul Ehrlich Inst Bundesamt Sera Impstoffe Frankf AM 1992, 85: 171-7
132.Nelson HS, Ikle D, and Buchmeier A, Studies of allergen extract stability: the effects of dilution and mixing. J Allergy Clin Immunol 1996, 98: 382-8
133.Mueller GA, Benjamin DC, Rule GS, Tertiary structure of the major house dust mite allergen Der p 2: sequential and structural homologies. Biochemistry 1998, 37: 12707-14
134.Smith AM, Benjamin DC, Derewenda U, Smith WA, Thomas WR, and Chapman MD, Sequence polymorphisms and antibody binding to the group 2 dust mite allergens. Int Arch Allergy Immunol 2001, 124: 61-63
135.Hoyne G, Bourne T, Kristensen N, Hetzel C, and Lamb J, From epitopes to peptides to immunotherapy. Clin Immunol Immunopathol 1996, 80: S23—30
136.Joost van Neerven RJ, Ebner C, Yssel H, Kapsenberg ML, and Lamb JR., T-cell responses to allergens: epitope-specificity and clinical rele-vance. Immunol Today 1996, 17: 526-32
137.Valenta R, Lidholm J, Niederberger V, Hayek B, Kraft D, and Gronlund H., The recombinant allergen-based concept of component resolved diagnostics and immunotherapy (CRD and CRIT). Clin Exp Allergy 1999, 29: 896-904
138.van Ree R, van Leeuwen A, Bulder I, Bond J, and Aalberse RC, Purified natural and recombinant Fel d 1 and cat albumin in in vitro diagnostics for cat allergy. J Allergy Clin Immunol 1999, 104: 1223-30
139.Scheiner O, and Kraft D, Basic and practical aspects of recombinant allergens. Allergy 1995, 50: 384-92
140.Chapman MD, Smith AM, Vailes LD, and Arruda LK, Recombinant mite allergens: new technologies for the management of patients with asthma. Allergy 1997, 52: 374-9
141.Thomas WR, and Smith W, Towards defining the full spectrum of house dust mite allergens. Clin Exp Allergy 1999, 29: 1583-7
142.Schramm G, Kahlert H, Suck R, Weber B, Stuwe HT, and Muller WD, et al., “Allergen engineering”: variants of the timothy grass pollen allergen Phl p 5b with reduced IgE-binding capacity but conserved T cell reactivity. J Immunol 1999, 162: 2406-13
143.Burks W, Bannon GA, Sicherer S, Sampson HA, Peanut-induced anaphylactic reactions. Int Arch Allergy Immunol 1999, 119: 165-72
144.Rabjohn P, Helm EM, Stanley JS, West CM, Sampson HA, and Burks AW, et al., Molecular cloning and epitope analysis of the peanut allergen Ara h 3. J Clin Invest 1999, 103: 535-42
145.Van Hage-Hamsten M, Kronqvist M, Zetterstrom O, Johansson E, Niederberger V, and Vrtala S, et al, Skin test evaluation of genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1: results obtained with a mix of two recombinant Bet v 1 fragments and recombinant Bet v 1 trimer in a Swedish population before the birch pollen season. J Allergy Clin Immunol 1999, 104: 969-77
146.Van Uden J, and Raz E, Immunostimulatory DNA and applications to allergic disease. J Allergy Clin Immunol 1999, 104: 902-10
147.Hansen G, Yeung VP, Berry G, Umetsu DT, and DeKruyff RH, Vaccination with heat-killed Listeria as adjuvant reverses established allergen-induced airway hyperreactivity and inflammation: role of CD8+ T cells and IL-18. J Immunol 2000, 164: 223-30
148.Koshte VL, Aalbers M, Calkoven PG, and Aalberse RC, The potent IgG4-inducing antigen in banana is a mannose binding lectin, BanLec-I. Int Arch Allergy Appl Immunol 1992, 97: 17-24
149.氣喘照護手冊, 行政院環境保護署, 1996.
|